[vc_column width=”1/1″][vc_column width=”1/1″][/vc_column]

pCPA Negotiation Status Update January 2019 – Two Oncology Negotiations Closed without LOI

February 14, 2019
-
Market Access News
Read More →
Posted by MORSE Team

Spotlight on the Atlantic Provinces: pCPA Letter of Intent Conversion and Time-to-Listing Analysis

January 24, 2019
-
Market Access News, Publications
Read More →
Posted by MORSE Team

pCPA Process Timelines Highlights – A Year-in-Review Primer

January 15, 2019
-
Market Access News
Read More →
Posted by MORSE Team

pCPA Complete its Most Active Month by Adjudicating 15 Files in November

December 20, 2018
-
Market Access News
Read More →
Posted by MORSE Team

International Experience with Pharmaceutical Managed Entry Agreements

December 13, 2018
-
Market Access News, Publications
Read More →
Posted by MORSE Team

BC Pharmacare Now Transitioning Patients on Copaxone® to GLATECT™

November 29, 2018
-
Market Access News
Read More →
Posted by MORSE Team

Number of Active pCPA Negotiations at an All-Time High and Continues to Climb

November 19, 2018
-
Market Access News
Read More →
Posted by MORSE Team

Significant Developments in Canadian Drugs for Rare Disease Policy

November 14, 2018
-
Market Access News
Read More →
Posted by MORSE Team

Presidents’ Roundtable – CAHR Market Access 201: Flying Blind – Navigating Patient Access through Uncertainty

November 8, 2018
-
Market Access News
Read More →
Posted by MORSE Team

Summary of the CADTH Drug Portfolio Information Session Nov. 2018

November 7, 2018
-
Market Access News
Read More →
Posted by MORSE Team

Patient Support Programs – CAHR Market Access 201: Flying Blind – Navigating Patient Access through Uncertainty

November 1, 2018
-
Market Access News
Read More →
Posted by MORSE Team

pCPA Panel – CAHR Market Access 201: Flying Blind – Navigating Patient Access through Uncertainty

October 25, 2018
-
Market Access News
Read More →
Posted by MORSE Team

Has RWE in Canada Reached a Tipping Point?

October 23, 2018
-
Market Access News
Read More →
Posted by Lorraine Boyle

HTA Panel – CAHR Market Access 201: Flying Blind – Navigating Patient Access through Uncertainty

October 18, 2018
-
Market Access News
Read More →
Posted by MORSE Team

Summary of the HC-HTA Alignment Webinar Sept. 2018

October 17, 2018
-
Market Access News
Read More →
Posted by MORSE Team
MORSE Market Access Signals - Latest in Pharmaceutical Reimbursement